News
23 Apr 2021
Neofact - Clinical evaluation of an applicator for surfactant administration
Neofact, by Lyomark Pharma, is a medical device for neonates suffering from RDS.
This study shows that the LISA method (less invasive administration) via Neofact® appears feasible.
Neofact® makes surfactant application easy and can also be used at any gestational age.
https://pubmed.ncbi.nlm.nih.gov/33023914/
Neofact for surfactant administration for RDS in preterm and term neonates.
Mentioned Companies
Lyomark Pharma GmbH
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance